Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

GALE 2.34 +0.01 (0.43%)
price chart
Why Galena Biopharma Inc. Stock Tumbled
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Galena Biopharma Reports Second Quarter 2014 Results  CNNMoney
Galena Biopharma Price Target Lowered to $7.00 at Needham & Company LLC ...  WKRB News
Related articles »  
Earnings Reaction History: Galena Biopharma, Inc., 66.7% Follow-Through ...
Galena Biopharma, Inc. ( GALE ) is due to issue its quarterly earnings report in the upcoming extended-hours session.
Market Movers: Galena Biopharma, Inc. (NASDAQ:GALE), Dominion Resources ...
On 11 AUG Galena Biopharma, Inc. (NASDAQ:GALE) last issued its quarterly earnings data on Monday. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.09) by $0.08.
Stocks Highlights: Galena Biopharma, Inc. (NASDAQ:GALE), Zogenix, Inc ...
Lakeway, NY - (MARKET NEWS CALL) - 8/20/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Traders Recap - Galena Biopharma Inc (NASDAQ:GALE), National Bank of ...
Galena Biopharma Inc (NASDAQ:GALE) reported its financial outcome for the quarter finished June 30, 2014 and provided a business update.
Related articles »  
Watch List: Tekmira Pharmaceuticals Corp (NASDAQ:TKMR), Galena ...
... investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on Tekmira Pharmaceuticals Corp (NASDAQ:TKMR), Galena Biopharma, Inc. (NASDAQ:GALE), ...
Related articles »  
Eye-Catching Stocks-SUPERVALU INC.(NYSE:SVU), Galena Biopharma Inc ...
Galena Biopharma Inc(NASDAQ:GALE) reported its financial results for the quarter ended June 30, 2014 and provided a business update.
Related articles »  
Traders Are Watching: JetBlue Airways Corporation (NASDAQ:JBLU), Galena ...
On 11 AUG Galena Biopharma, Inc. (NASDAQ:GALE) reported ($0.17) earnings per share for the quarter, missing the analysts' consensus estimate of ($0.09) by $0.08.
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma ...
Galena Biopharma, Inc. GALE, -4.12% is a Portland, Oregon-based biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.
Galena secures U.S. rights to serotonin blocker (GALE)  Seeking Alpha
Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for ...  CNNMoney
Related articles »  
Top Biotech Stories: Dendreon Corporation (NASDAQ:DNDN), Galena ...
Galena Biopharma Inc (NASDAQ:GALE) lost 8.82% after the company reported a larger-than-expected loss as revenue rose to $2.5 million from $0 a year earlier.